info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Peptic Ulcer Drugs Companies

several pharmaceutical companies are involved in the development and production of drugs for peptic ulcers. It's important to note that the status and details of these companies may have changed since then, and it's advisable to check the latest information from reliable sources for the most up-to-date details. 

Peptic Ulcer Drugs Market

 


Latest Peptic Ulcer Drugs Companies Updates:


Cadila Healthcare Ltd. received USFDA nod for their ulcer treatment injection, Esomeprazole Sodium, expanding their product portfolio and market reach.


Takeda Pharmaceutical Company Limited launched a novel formulation of lansoprazole for oral suspension, catering to patients with swallowing difficulties.


Daewoong Pharmaceutical Co., Ltd. unveiled a new H. pylori eradication kit combining their clarithromycin-based antibiotic with omeprazole, aiming for improved treatment success rates.


Pfizer Inc. announced plans to expand their OTC portfolio by acquiring a leading brand of antacids, strengthening their presence in the market.


Abbott Laboratories partnered with a research institute to develop a novel diagnostic test for H. pylori that integrates with their existing Point-of-Care platform, aiming for rapid and accessible diagnosis.


 


List of Peptic Ulcer Drugs Key companies in the market:




  • Novartis AG




  • Daiichi Sankyo Company Limited




  • Acetelion Ltd, Boehringer Ingelheim




  • Sanofi S.A.




  • Astra Zeneca plc




  • Ranbaxy Laboratories Limited, Inc.




  • Takeda Pharmaceuticals Company Limited




  • Pfizer Inc. Helicure AB




Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.